A Quiet Migration South
The LA Times tracks a quietly growing migration of high-profile athletes traveling to Mexico for ibogaine therapy, a Schedule I psychedelic with no approved medical use in the United States but mounting evidence of dramatic benefit for traumatic brain injury and trauma-related conditions.
Athletes referenced include Athletes for Care co-founder Robert Gallery, retired MMA fighter Tait Fletcher, Pro Football Hall of Famer Brett Favre, retired NHL forward Ales Hemsky, and former UFC fighter Keith Jardine.
The Stanford Data
The piece highlights the Stanford observational study of 30 special forces veterans who received ibogaine treatment, showing average reductions of:
- 88% in PTSD symptoms
- 87% in depression
- 81% in anxiety
Researchers point to ibogaine’s apparent ability to stimulate neurotrophic factors and promote brain healing.
Voices from the Field
“I’m not anxious all the time, I’m not depressed.” — Robert Gallery, on life after treatment
Tait Fletcher, who suffered severe head trauma in a stunt accident, credits ibogaine with eliminating suicidal ideation. Hemsky reported seven months of sobriety post-treatment.
What’s Next
Texas has approved $50 million in state funding for ibogaine clinical trials, with Arizona and California supporting additional research. Experts emphasize that larger trials and strict cardiac monitoring are essential before widespread adoption.
Athletes for Care continues to advocate for the research, regulatory pathways, and access that will let athletes heal at home.
Join Us
Stand with us.
Support the mission.
Donate now and help us change the game—for good.